Alphabet kickstarts new AI drug discovery outfit with lessons learned from DeepMind protein breakthroughs

Last summer marked a major breakthrough in drug discovery when DeepMind, a predictive modeling startup from Google parent company Alphabet, offered the most accurate picture yet of the “protein folding” problem. The Alphabet team is now propping up a unit focused solely on drug discovery, and it will look to leverage lessons learned from DeepMind’s example.